Nuclear Medicine AtlasInteractive atlas

Lu-177 PRRT Kidney BED Tracker

Cumulative renal biologically-effective dose across PRRT cycles, with the tolerance thresholds and remaining headroom

#tool#therapy#theranostics#dosimetry#safety
High-yield mode — key points, high-yield facts, tables & quizzes only. Toggle off for full text.

Kidney biologically effective dose (BED) is the accepted way to track cumulative renal risk across PRRT cycles, because it accounts for dose rate and sublethal-damage repair rather than absorbed dose alone. For each administration, BED = D · [1 + (D / (α/β)) · λ/(μ+λ)], with kidney α/β ≈ 2.6 Gy, repair half-time ≈ 2.8 h, and λ from the kidney effective half-life; cycle BEDs are additive. Widely used tolerance thresholds are ~40 Gy BED without renal risk factors and ~28 Gy with them (hypertension, diabetes), against the classic 23 Gy absorbed-dose TD₅/₅. Enter each cycle's kidney absorbed dose to track cumulative BED and remaining headroom.

Lu-177 PRRT — cumulative kidney BED
Per cycle, BED = D × [1 + (D / (α/β)) × λ/(μ+λ)], with λ = ln2/Teff (kidney) and μ = ln2/repair‑half‑time; cycle BEDs are additive. Defaults: α/β = 2.6 Gy, repair half-time 2.8 h (Barone/Wessels). Tolerance ≈ 40 Gy BED without renal risk factors, 28 Gy with them; classic absorbed-dose TD₅/₅ is 23 Gy. Uses one shared effective half-life for all cycles — enter per-cycle absorbed doses from your imaging-based dosimetry. Educational estimate — confirm with medical physics and your institutional protocol.
Nuclear Medicine Atlas · v1.76 · built 2026-10-25Terms · Privacy · Disclaimer